Connect with others who understand.

Sign up Log in
About MyPrurigoTeam
Powered By
Real members of MyPrurigoTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Curious Did Anyone Email The FDA Concerning The New Drug, Nemolizumab Which Is Under Priority Review?

A MyPrurigoTeam Member asked a question 💭
Tooele, UT
June 11
•
View reactions
A MyPrurigoTeam Member

Having participated in clinical trials as an investigator whilst the length of time to bring a drug is frustrating for the patient to say the least, it's really for your protection and benefit. The last thing pharmaceutical companies want to happen is adverse, significant side effects or death.

June 12
A MyPrurigoTeam Member

I did and got an answer......actually not what I really wanted to hear because of the govt structure ruling for the FDA! Go figure, but I don't know how to do attachments on here (maybe camera) to send my question and their answer to it! I would just like to know how long it took for the Cancer treatments to finally be approved, hmmm!👀

June 11
A MyPrurigoTeam Member
June 12
A MyPrurigoTeam Member

Right, we kind of Passed the March timeframe...

June 12
A MyPrurigoTeam Member

Thx DanaCargile that explained a lot of information that I was not aware of, but unless I missed it but no estimated timeframe as to when!🦋

June 12

Related content

View All

Would Any Support Team Members Be Willing To Email The FDA?

A MyPrurigoTeam Member asked a question 💭
Tooele, UT

Has Anyone Tried Capsaicin On Their Scalp Pn

A MyPrurigoTeam Member asked a question 💭
Tooele, UT

Previously, The FDA Granted Nemolizumab Breakthrough Therapy For The Treatment Of Pruritus Associated With Prurigo Nodularis In December 201

A MyPrurigoTeam Member asked a question 💭
Lynchburg, VA
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data Policy and Privacy policies.Your privacy is our priority Lock Icon
Already a Member? Log in